NewGenIvf Group Limited Stock Price Patterns
| NIVF Stock | 0.52 -0.0049 -0.94% |
Momentum
Sell Stretched
Oversold | Overbought |
EPS Estimate Current Year -32.85 | EPS Estimate Next Year 23.85 | Wall Street Target Price 225 | Quarterly Revenue Growth -0.13 |
This view maps NewGenIvf Group Limited attention shifts to recent price behavior and peer activity.
This module places attention patterns for NewGenIvf Group alongside recent price behavior for context.
NewGenIvf Group after-hype prediction price | $ 0.52 |
The hype panel supports comparisons with forecasting models, technical signals, analyst consensus, and earnings.
NewGenIvf | Build AI portfolio with NewGenIvf Stock |
Valuation-driven investors use mean reversion to time NewGenIvf Group's investments: buying when it trades materially below its historical average valuation multiples and selling when it reaches premium territory.
NewGenIvf Group After-Hype Price Density Analysis
The price distribution chart for NewGenIvf Group visualizes our statistical uncertainty about NewGenIvf Group's future price. This uncertainty is inherent in all forecasting, and any model claiming to eliminate it for NewGenIvf Group should be viewed with skepticism.
Next price density |
| Expected price to next headline |
NewGenIvf Group Estimiated After-Hype Price Volatility
Our news impact model for NewGenIvf Group estimates the statistical distribution of after-hype price outcomes based on NewGenIvf Group's historical reactions to comparable events. NewGenIvf Group's after-hype downside and upside margins for the prediction period are 0.03 and 9.99, respectively. The model is descriptive rather than predictive and reflects what has historically happened - not what will.
Current Value
The after-hype framework applied to NewGenIvf Group Limited assumes a 3 months review window and focuses on post-sentiment normalization rather than raw momentum. This view is most useful when investors want to compare sentiment-driven price extension with a more measured post-news scenario.
NewGenIvf Group Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as NewGenIvf Group is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading NewGenIvf Group backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with NewGenIvf Group, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
2.51 | 9.27 | 0.40 | 0.02 | 5 Events | 4 Events | In 5 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.52 | 0.52 | 0.00 |
|
NewGenIvf Group Hype Timeline
NewGenIvf Group is now traded for 0.52. The company has historical hype elasticity of -0.4, and average elasticity to hype of competition of -0.02. NewGenIvf is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is now at -2.51%. %. The volatility of related hype on NewGenIvf Group is about 132428.57%, with the expected price after the next announcement by competition of 0.50. The company has price-to-book ratio of 0.02. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. NewGenIvf Group recorded earning per share (EPS) of 4195.34. The company had not issued any dividends in recent years. The firm completed a 1:3 stock split on 26th of January 2026. Given the investment horizon of 90 days the next anticipated press release will be in 5 days. NewGenIvf Group Basic Forecasting Models provides a cross-check on projections for NewGenIvf Group. The models provide a structured reference point.NewGenIvf Group Related Hype Analysis
The peer hype summary table for NewGenIvf Group serves as a competitive intelligence tool, helping investors understand the news sensitivity landscape around NewGenIvf Group's sector and identify the companies most likely to influence NewGenIvf Group's near-term performance.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| WORX | Scworx Corp | 0.01 | 6 per month | 0.00 | -0.01 | 15.38 | -16.67 | 79.94 | |
| HEPA | Hepion Pharmaceuticals | 0.04 | 9 per month | 0.00 | -0.44 | 13.95 | -25.00 | 78.13 | |
| ZVSA | ZyVersa Therapeutics | 0.01 | 6 per month | 6.14 | 0.14 | 17.65 | -11.54 | 86.14 | |
| CDT | Conduit Pharmaceuticals | -0.02 | 7 per month | 0.00 | -0.21 | 12.43 | -10.58 | 40.12 | |
| IVF | INVO Fertility | -0.04 | 10 per month | 7.44 | 0.03 | 12.22 | -12.96 | 218.36 | |
| COCH | Envoy Medical | -0.06 | 9 per month | 5.47 | 0.03 | 10.29 | -9.23 | 90.44 | |
| PETV | PetVivo Holdings | 0.00 | 0 per month | 0.00 | -0.12 | 5.71 | -6.98 | 19.35 | |
| CCM | Concord Medical Services | -0.03 | 10 per month | 4.71 | 0.04 | 12.41 | -7.83 | 25.36 | |
| PTPI | Petros Pharmaceuticals | 0.00 | 0 per month | 0.00 | -0.04 | 14.29 | -12.50 | 45.83 | |
| XAGE | Longevity Health Holdings | 0.02 | 7 per month | 0.00 | -0.02 | 16.67 | -11.11 | 46.18 |
NewGenIvf Group Additional Predictive Modules
Most predictive techniques to examine NewGenIvf price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for NewGenIvf using various technical indicators. When you analyze NewGenIvf charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About NewGenIvf Group Sentiment
Sentiment analysis for NewGenIvf Group evaluates news tone, positioning, and narrative momentum. Information shocks can change volatility expectations abruptly. NewGenIvf Group has a market cap of 545.84 K, ROE of 1.61%. 
Ellen Johnson ยท Member of Macroaxis Editorial Board
Unless otherwise specified, financial data for NewGenIvf Group Limited is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Updates may occur throughout the day.
NewGenIvf Stock is Curated By:
Ellen Johnson ยท Member of Macroaxis Editorial BoardCurrently Active Assets on Macroaxis
Popular Tools for NewGenIvf Stock analysis
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Holdings Check your current holdings and cash position to determine if your portfolio needs rebalancing | |
| Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |